/ /

  • linkedin
  • Increase Font
  • Sharebar

    4 things you missed at SECO 2016

    Atlanta—Didn’t make it to Atlanta for SECO this year? That’s OK—we’ve got you covered. Check out all the latest news you may have missed.

    Missed any of our SECO coverage? Click here to check out what you missed!

    B+L launches Ultra for Presbyopia

    Bausch + Lomb introduced its Bausch + Lomb Ultra for Presbyopia contact lenses, a monthly replacement silicone hydrogel lens that combines the company’s MoistureSeal technology with the 3-Zone Progressive design found in Biotrue ONEday for Presbyopia daily disposable contact lenses.

    According to the company, the combination of these advanced proprietary technologies provides presbyopic patients comfort and vision at near, intermediate, and distance while also providing eyecare professionals (ECPs) the convenience of easy and predictable lens fitting.

    “Many of my multifocal lens-wearing patients are spending more time using digital devices and they struggle with dryness and vision, especially looking at their cell phones and working on their computer for prolonged periods,” says Ben Gaddie, OD, in Louisville, KY. “Bausch + Lomb Ultra lenses are my monthly lens of choice and my patients continue to be very impressed with their wearing experience. To have this technology available for my presbyopic patients in a lens that is easy-to-fit and provides exceptional comfort and outstanding near, intermediate and distance vision, will be a welcomed addition in my practice.”

    The Bausch + Lomb Ultra for Presbyopia contact lenses will begin distribution in March 2016.

    More from SECO 2016: Tips for caring for disabled patients

    Colleen E. McCarthy
    Colleen McCarthy is a freelance writer based in the Cleveland area and a former editor of Optometry Times. She is a 2010 graduate of the ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V